IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q1 2024 Holdings

Filed 2024-05-14 | 60 holdings | $122.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Silk Road Medical IncCOM82710M100$2.9M158,0942.4%
Quidelortho CorpCOM74838J101$3.1M65,2032.6%
Prothena Corp PLC(PRTA)SHSG72800108$4.2M169,5743.4%
Ovintiv Inc(OVV)COM69047Q102$4.4M84,2003.6%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$4.6M250,4003.8%
Elutia Inc(ELUT)COM05479K106$5.2M1,655,1844.3%
Biodesix IncCOM09075X108$7.4M5,193,3366.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$10.7M77,2408.7%
Bristol-Myers Squibb Co(BMY)COM110122108$38.2M703,60631.2%
PreviousPage 2 of 2